nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—POR—Doxorubicin—ovarian cancer	0.284	0.363	CbGbCtD
Nitrofurantoin—ABCG2—Topotecan—ovarian cancer	0.193	0.247	CbGbCtD
Nitrofurantoin—ABCG2—Paclitaxel—ovarian cancer	0.0958	0.122	CbGbCtD
Nitrofurantoin—ABCG2—Carboplatin—ovarian cancer	0.0901	0.115	CbGbCtD
Nitrofurantoin—ABCG2—Docetaxel—ovarian cancer	0.0692	0.0882	CbGbCtD
Nitrofurantoin—ABCG2—Doxorubicin—ovarian cancer	0.0516	0.0658	CbGbCtD
Nitrofurantoin—POR—myometrium—ovarian cancer	0.00397	0.117	CbGeAlD
Nitrofurantoin—POR—uterine cervix—ovarian cancer	0.00309	0.0909	CbGeAlD
Nitrofurantoin—POR—decidua—ovarian cancer	0.00295	0.0866	CbGeAlD
Nitrofurantoin—POR—endometrium—ovarian cancer	0.0028	0.0822	CbGeAlD
Nitrofurantoin—POR—bone marrow—ovarian cancer	0.00219	0.0643	CbGeAlD
Nitrofurantoin—POR—female gonad—ovarian cancer	0.00211	0.0619	CbGeAlD
Nitrofurantoin—POR—vagina—ovarian cancer	0.0021	0.0616	CbGeAlD
Nitrofurantoin—POR—testis—ovarian cancer	0.00187	0.0549	CbGeAlD
Nitrofurantoin—ABCG2—myometrium—ovarian cancer	0.00185	0.0542	CbGeAlD
Nitrofurantoin—ABCG2—uterine cervix—ovarian cancer	0.00144	0.0422	CbGeAlD
Nitrofurantoin—ABCG2—decidua—ovarian cancer	0.00137	0.0402	CbGeAlD
Nitrofurantoin—POR—lymph node—ovarian cancer	0.00136	0.0398	CbGeAlD
Nitrofurantoin—ABCG2—endometrium—ovarian cancer	0.0013	0.0382	CbGeAlD
Nitrofurantoin—ABCG2—uterus—ovarian cancer	0.0012	0.0352	CbGeAlD
Nitrofurantoin—ABCG2—bone marrow—ovarian cancer	0.00102	0.0299	CbGeAlD
Nitrofurantoin—ABCG2—female gonad—ovarian cancer	0.00098	0.0288	CbGeAlD
Nitrofurantoin—ABCG2—vagina—ovarian cancer	0.000974	0.0286	CbGeAlD
Nitrofurantoin—ABCG2—testis—ovarian cancer	0.000869	0.0255	CbGeAlD
Nitrofurantoin—ABCG2—lymph node—ovarian cancer	0.00063	0.0185	CbGeAlD
Nitrofurantoin—Feeling abnormal—Chlorambucil—ovarian cancer	0.000431	0.00238	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000428	0.00236	CcSEcCtD
Nitrofurantoin—Cough—Vinorelbine—ovarian cancer	0.000426	0.00235	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000425	0.00234	CcSEcCtD
Nitrofurantoin—Paraesthesia—Topotecan—ovarian cancer	0.000419	0.00231	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.000417	0.0023	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.000416	0.0023	CcSEcCtD
Nitrofurantoin—Chest pain—Vinorelbine—ovarian cancer	0.000416	0.00229	CcSEcCtD
Nitrofurantoin—Myalgia—Vinorelbine—ovarian cancer	0.000416	0.00229	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000416	0.00229	CcSEcCtD
Nitrofurantoin—Dyspnoea—Topotecan—ovarian cancer	0.000416	0.00229	CcSEcCtD
Nitrofurantoin—Abdominal pain—Chlorambucil—ovarian cancer	0.000414	0.00228	CcSEcCtD
Nitrofurantoin—Body temperature increased—Chlorambucil—ovarian cancer	0.000414	0.00228	CcSEcCtD
Nitrofurantoin—Renal failure—Paclitaxel—ovarian cancer	0.000413	0.00228	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.000412	0.00227	CcSEcCtD
Nitrofurantoin—Discomfort—Vinorelbine—ovarian cancer	0.000411	0.00227	CcSEcCtD
Nitrofurantoin—Dyspepsia—Topotecan—ovarian cancer	0.00041	0.00226	CcSEcCtD
Nitrofurantoin—Paraesthesia—Melphalan—ovarian cancer	0.00041	0.00226	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.000408	0.00225	CcSEcCtD
Nitrofurantoin—Dyspnoea—Melphalan—ovarian cancer	0.000407	0.00224	CcSEcCtD
Nitrofurantoin—Decreased appetite—Topotecan—ovarian cancer	0.000405	0.00224	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Epirubicin—ovarian cancer	0.000403	0.00223	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000402	0.00222	CcSEcCtD
Nitrofurantoin—Dyspepsia—Melphalan—ovarian cancer	0.000402	0.00222	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000399	0.0022	CcSEcCtD
Nitrofurantoin—Constipation—Topotecan—ovarian cancer	0.000399	0.0022	CcSEcCtD
Nitrofurantoin—Decreased appetite—Melphalan—ovarian cancer	0.000397	0.00219	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000394	0.00217	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00039	0.00215	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000386	0.00213	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Topotecan—ovarian cancer	0.000384	0.00212	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Topotecan—ovarian cancer	0.000381	0.0021	CcSEcCtD
Nitrofurantoin—Anorexia—Vinorelbine—ovarian cancer	0.00038	0.0021	CcSEcCtD
Nitrofurantoin—Asthenia—Chlorambucil—ovarian cancer	0.000376	0.00207	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Paclitaxel—ovarian cancer	0.000376	0.00207	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Doxorubicin—ovarian cancer	0.000373	0.00206	CcSEcCtD
Nitrofurantoin—Abdominal pain—Topotecan—ovarian cancer	0.000368	0.00203	CcSEcCtD
Nitrofurantoin—Body temperature increased—Topotecan—ovarian cancer	0.000368	0.00203	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000363	0.002	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Epirubicin—ovarian cancer	0.000359	0.00198	CcSEcCtD
Nitrofurantoin—Diarrhoea—Chlorambucil—ovarian cancer	0.000358	0.00198	CcSEcCtD
Nitrofurantoin—Paraesthesia—Vinorelbine—ovarian cancer	0.000358	0.00198	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Paclitaxel—ovarian cancer	0.000357	0.00197	CcSEcCtD
Nitrofurantoin—Dyspnoea—Vinorelbine—ovarian cancer	0.000355	0.00196	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000353	0.00195	CcSEcCtD
Nitrofurantoin—Renal failure—Docetaxel—ovarian cancer	0.00035	0.00193	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Docetaxel—ovarian cancer	0.000349	0.00193	CcSEcCtD
Nitrofurantoin—Decreased appetite—Vinorelbine—ovarian cancer	0.000347	0.00191	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000344	0.0019	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Topotecan—ovarian cancer	0.000343	0.00189	CcSEcCtD
Nitrofurantoin—Constipation—Vinorelbine—ovarian cancer	0.000341	0.00188	CcSEcCtD
Nitrofurantoin—Chills—Paclitaxel—ovarian cancer	0.000339	0.00187	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Melphalan—ovarian cancer	0.000336	0.00186	CcSEcCtD
Nitrofurantoin—Asthenia—Topotecan—ovarian cancer	0.000334	0.00185	CcSEcCtD
Nitrofurantoin—Alopecia—Paclitaxel—ovarian cancer	0.000334	0.00184	CcSEcCtD
Nitrofurantoin—Vomiting—Chlorambucil—ovarian cancer	0.000333	0.00184	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Docetaxel—ovarian cancer	0.000333	0.00184	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000332	0.00183	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000331	0.00182	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Vinorelbine—ovarian cancer	0.000329	0.00181	CcSEcCtD
Nitrofurantoin—Renal impairment—Epirubicin—ovarian cancer	0.000328	0.00181	CcSEcCtD
Nitrofurantoin—Asthenia—Melphalan—ovarian cancer	0.000327	0.00181	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000326	0.0018	CcSEcCtD
Nitrofurantoin—Flatulence—Paclitaxel—ovarian cancer	0.000324	0.00179	CcSEcCtD
Nitrofurantoin—Hepatitis—Docetaxel—ovarian cancer	0.00032	0.00177	CcSEcCtD
Nitrofurantoin—Diarrhoea—Topotecan—ovarian cancer	0.000319	0.00176	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Docetaxel—ovarian cancer	0.000318	0.00176	CcSEcCtD
Nitrofurantoin—Abdominal pain—Vinorelbine—ovarian cancer	0.000315	0.00174	CcSEcCtD
Nitrofurantoin—Body temperature increased—Vinorelbine—ovarian cancer	0.000315	0.00174	CcSEcCtD
Nitrofurantoin—Diarrhoea—Melphalan—ovarian cancer	0.000312	0.00172	CcSEcCtD
Nitrofurantoin—Nausea—Chlorambucil—ovarian cancer	0.000311	0.00172	CcSEcCtD
Nitrofurantoin—Dizziness—Topotecan—ovarian cancer	0.000308	0.0017	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000306	0.00169	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000305	0.00168	CcSEcCtD
Nitrofurantoin—Anaemia—Paclitaxel—ovarian cancer	0.000304	0.00168	CcSEcCtD
Nitrofurantoin—Renal impairment—Doxorubicin—ovarian cancer	0.000303	0.00167	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Docetaxel—ovarian cancer	0.000303	0.00167	CcSEcCtD
Nitrofurantoin—Vomiting—Topotecan—ovarian cancer	0.000296	0.00164	CcSEcCtD
Nitrofurantoin—Malaise—Paclitaxel—ovarian cancer	0.000296	0.00163	CcSEcCtD
Nitrofurantoin—Vertigo—Paclitaxel—ovarian cancer	0.000295	0.00163	CcSEcCtD
Nitrofurantoin—Leukopenia—Paclitaxel—ovarian cancer	0.000294	0.00162	CcSEcCtD
Nitrofurantoin—Rash—Topotecan—ovarian cancer	0.000294	0.00162	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000294	0.00162	CcSEcCtD
Nitrofurantoin—Headache—Topotecan—ovarian cancer	0.000292	0.00161	CcSEcCtD
Nitrofurantoin—Vomiting—Melphalan—ovarian cancer	0.00029	0.0016	CcSEcCtD
Nitrofurantoin—Rash—Melphalan—ovarian cancer	0.000288	0.00159	CcSEcCtD
Nitrofurantoin—Chills—Docetaxel—ovarian cancer	0.000287	0.00158	CcSEcCtD
Nitrofurantoin—Cough—Paclitaxel—ovarian cancer	0.000287	0.00158	CcSEcCtD
Nitrofurantoin—Asthenia—Vinorelbine—ovarian cancer	0.000286	0.00158	CcSEcCtD
Nitrofurantoin—Alopecia—Docetaxel—ovarian cancer	0.000283	0.00156	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000281	0.00155	CcSEcCtD
Nitrofurantoin—Chest pain—Paclitaxel—ovarian cancer	0.00028	0.00154	CcSEcCtD
Nitrofurantoin—Myalgia—Paclitaxel—ovarian cancer	0.00028	0.00154	CcSEcCtD
Nitrofurantoin—Nausea—Topotecan—ovarian cancer	0.000277	0.00153	CcSEcCtD
Nitrofurantoin—Discomfort—Paclitaxel—ovarian cancer	0.000276	0.00153	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000275	0.00152	CcSEcCtD
Nitrofurantoin—Diarrhoea—Vinorelbine—ovarian cancer	0.000273	0.00151	CcSEcCtD
Nitrofurantoin—Nausea—Melphalan—ovarian cancer	0.000271	0.0015	CcSEcCtD
Nitrofurantoin—Confusional state—Paclitaxel—ovarian cancer	0.00027	0.00149	CcSEcCtD
Nitrofurantoin—Asthma—Epirubicin—ovarian cancer	0.00027	0.00149	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000268	0.00148	CcSEcCtD
Nitrofurantoin—Eosinophilia—Epirubicin—ovarian cancer	0.000267	0.00147	CcSEcCtD
Nitrofurantoin—Dizziness—Vinorelbine—ovarian cancer	0.000264	0.00145	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000263	0.00145	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00026	0.00143	CcSEcCtD
Nitrofurantoin—Anaemia—Docetaxel—ovarian cancer	0.000257	0.00142	CcSEcCtD
Nitrofurantoin—Anorexia—Paclitaxel—ovarian cancer	0.000256	0.00141	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000255	0.0014	CcSEcCtD
Nitrofurantoin—Vomiting—Vinorelbine—ovarian cancer	0.000254	0.0014	CcSEcCtD
Nitrofurantoin—Rash—Vinorelbine—ovarian cancer	0.000251	0.00139	CcSEcCtD
Nitrofurantoin—Headache—Vinorelbine—ovarian cancer	0.00025	0.00138	CcSEcCtD
Nitrofurantoin—Asthma—Doxorubicin—ovarian cancer	0.000249	0.00138	CcSEcCtD
Nitrofurantoin—Leukopenia—Docetaxel—ovarian cancer	0.000249	0.00138	CcSEcCtD
Nitrofurantoin—Eosinophilia—Doxorubicin—ovarian cancer	0.000247	0.00136	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000244	0.00135	CcSEcCtD
Nitrofurantoin—Cough—Docetaxel—ovarian cancer	0.000243	0.00134	CcSEcCtD
Nitrofurantoin—Paraesthesia—Paclitaxel—ovarian cancer	0.000241	0.00133	CcSEcCtD
Nitrofurantoin—Drowsiness—Epirubicin—ovarian cancer	0.00024	0.00133	CcSEcCtD
Nitrofurantoin—Dyspnoea—Paclitaxel—ovarian cancer	0.000239	0.00132	CcSEcCtD
Nitrofurantoin—Somnolence—Paclitaxel—ovarian cancer	0.000238	0.00132	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000238	0.00131	CcSEcCtD
Nitrofurantoin—Myalgia—Docetaxel—ovarian cancer	0.000237	0.00131	CcSEcCtD
Nitrofurantoin—Chest pain—Docetaxel—ovarian cancer	0.000237	0.00131	CcSEcCtD
Nitrofurantoin—Nausea—Vinorelbine—ovarian cancer	0.000237	0.00131	CcSEcCtD
Nitrofurantoin—Renal failure—Epirubicin—ovarian cancer	0.000236	0.0013	CcSEcCtD
Nitrofurantoin—Dyspepsia—Paclitaxel—ovarian cancer	0.000236	0.0013	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000236	0.0013	CcSEcCtD
Nitrofurantoin—Decreased appetite—Paclitaxel—ovarian cancer	0.000233	0.00129	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000232	0.00128	CcSEcCtD
Nitrofurantoin—Constipation—Paclitaxel—ovarian cancer	0.000229	0.00127	CcSEcCtD
Nitrofurantoin—Confusional state—Docetaxel—ovarian cancer	0.000229	0.00126	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000227	0.00125	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Epirubicin—ovarian cancer	0.000224	0.00124	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000223	0.00123	CcSEcCtD
Nitrofurantoin—Drowsiness—Doxorubicin—ovarian cancer	0.000222	0.00123	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000221	0.00122	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000221	0.00122	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000219	0.00121	CcSEcCtD
Nitrofurantoin—Renal failure—Doxorubicin—ovarian cancer	0.000219	0.00121	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000218	0.0012	CcSEcCtD
Nitrofurantoin—Anorexia—Docetaxel—ovarian cancer	0.000217	0.0012	CcSEcCtD
Nitrofurantoin—Hepatitis—Epirubicin—ovarian cancer	0.000216	0.00119	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Epirubicin—ovarian cancer	0.000215	0.00118	CcSEcCtD
Nitrofurantoin—Body temperature increased—Paclitaxel—ovarian cancer	0.000212	0.00117	CcSEcCtD
Nitrofurantoin—Abdominal pain—Paclitaxel—ovarian cancer	0.000212	0.00117	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000208	0.00115	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000207	0.00114	CcSEcCtD
Nitrofurantoin—Paraesthesia—Docetaxel—ovarian cancer	0.000204	0.00113	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Epirubicin—ovarian cancer	0.000204	0.00113	CcSEcCtD
Nitrofurantoin—Dyspnoea—Docetaxel—ovarian cancer	0.000203	0.00112	CcSEcCtD
Nitrofurantoin—Somnolence—Docetaxel—ovarian cancer	0.000202	0.00111	CcSEcCtD
Nitrofurantoin—Dyspepsia—Docetaxel—ovarian cancer	0.0002	0.0011	CcSEcCtD
Nitrofurantoin—Hepatitis—Doxorubicin—ovarian cancer	0.0002	0.0011	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000199	0.0011	CcSEcCtD
Nitrofurantoin—Decreased appetite—Docetaxel—ovarian cancer	0.000198	0.00109	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000198	0.00109	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000196	0.00108	CcSEcCtD
Nitrofurantoin—Constipation—Docetaxel—ovarian cancer	0.000194	0.00107	CcSEcCtD
Nitrofurantoin—Chills—Epirubicin—ovarian cancer	0.000194	0.00107	CcSEcCtD
Nitrofurantoin—Asthenia—Paclitaxel—ovarian cancer	0.000192	0.00106	CcSEcCtD
Nitrofurantoin—Alopecia—Epirubicin—ovarian cancer	0.000191	0.00105	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Doxorubicin—ovarian cancer	0.000189	0.00104	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Docetaxel—ovarian cancer	0.000187	0.00103	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000186	0.00103	CcSEcCtD
Nitrofurantoin—Flatulence—Epirubicin—ovarian cancer	0.000185	0.00102	CcSEcCtD
Nitrofurantoin—Diarrhoea—Paclitaxel—ovarian cancer	0.000183	0.00101	CcSEcCtD
Nitrofurantoin—Abdominal pain—Docetaxel—ovarian cancer	0.00018	0.000991	CcSEcCtD
Nitrofurantoin—Body temperature increased—Docetaxel—ovarian cancer	0.00018	0.000991	CcSEcCtD
Nitrofurantoin—Chills—Doxorubicin—ovarian cancer	0.000179	0.000989	CcSEcCtD
Nitrofurantoin—Dizziness—Paclitaxel—ovarian cancer	0.000177	0.000978	CcSEcCtD
Nitrofurantoin—Alopecia—Doxorubicin—ovarian cancer	0.000176	0.000974	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000174	0.000962	CcSEcCtD
Nitrofurantoin—Anaemia—Epirubicin—ovarian cancer	0.000174	0.000958	CcSEcCtD
Nitrofurantoin—Flatulence—Doxorubicin—ovarian cancer	0.000171	0.000945	CcSEcCtD
Nitrofurantoin—Vomiting—Paclitaxel—ovarian cancer	0.000171	0.000941	CcSEcCtD
Nitrofurantoin—Malaise—Epirubicin—ovarian cancer	0.000169	0.000935	CcSEcCtD
Nitrofurantoin—Rash—Paclitaxel—ovarian cancer	0.000169	0.000933	CcSEcCtD
Nitrofurantoin—Vertigo—Epirubicin—ovarian cancer	0.000169	0.000931	CcSEcCtD
Nitrofurantoin—Leukopenia—Epirubicin—ovarian cancer	0.000168	0.000928	CcSEcCtD
Nitrofurantoin—Headache—Paclitaxel—ovarian cancer	0.000168	0.000927	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Docetaxel—ovarian cancer	0.000167	0.000924	CcSEcCtD
Nitrofurantoin—Cough—Epirubicin—ovarian cancer	0.000164	0.000904	CcSEcCtD
Nitrofurantoin—Asthenia—Docetaxel—ovarian cancer	0.000163	0.0009	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000161	0.00089	CcSEcCtD
Nitrofurantoin—Anaemia—Doxorubicin—ovarian cancer	0.000161	0.000886	CcSEcCtD
Nitrofurantoin—Chest pain—Epirubicin—ovarian cancer	0.00016	0.000882	CcSEcCtD
Nitrofurantoin—Myalgia—Epirubicin—ovarian cancer	0.00016	0.000882	CcSEcCtD
Nitrofurantoin—Nausea—Paclitaxel—ovarian cancer	0.000159	0.000879	CcSEcCtD
Nitrofurantoin—Discomfort—Epirubicin—ovarian cancer	0.000158	0.000872	CcSEcCtD
Nitrofurantoin—Malaise—Doxorubicin—ovarian cancer	0.000157	0.000865	CcSEcCtD
Nitrofurantoin—Vertigo—Doxorubicin—ovarian cancer	0.000156	0.000862	CcSEcCtD
Nitrofurantoin—Leukopenia—Doxorubicin—ovarian cancer	0.000156	0.000858	CcSEcCtD
Nitrofurantoin—Diarrhoea—Docetaxel—ovarian cancer	0.000156	0.000858	CcSEcCtD
Nitrofurantoin—Confusional state—Epirubicin—ovarian cancer	0.000155	0.000853	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000153	0.000846	CcSEcCtD
Nitrofurantoin—Cough—Doxorubicin—ovarian cancer	0.000152	0.000837	CcSEcCtD
Nitrofurantoin—Dizziness—Docetaxel—ovarian cancer	0.00015	0.000829	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Epirubicin—ovarian cancer	0.00015	0.000828	CcSEcCtD
Nitrofurantoin—Chest pain—Doxorubicin—ovarian cancer	0.000148	0.000816	CcSEcCtD
Nitrofurantoin—Myalgia—Doxorubicin—ovarian cancer	0.000148	0.000816	CcSEcCtD
Nitrofurantoin—Discomfort—Doxorubicin—ovarian cancer	0.000146	0.000807	CcSEcCtD
Nitrofurantoin—Anorexia—Epirubicin—ovarian cancer	0.000146	0.000806	CcSEcCtD
Nitrofurantoin—Vomiting—Docetaxel—ovarian cancer	0.000145	0.000797	CcSEcCtD
Nitrofurantoin—Rash—Docetaxel—ovarian cancer	0.000143	0.000791	CcSEcCtD
Nitrofurantoin—Confusional state—Doxorubicin—ovarian cancer	0.000143	0.000789	CcSEcCtD
Nitrofurantoin—Headache—Docetaxel—ovarian cancer	0.000142	0.000786	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000142	0.000783	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00014	0.000771	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000139	0.000766	CcSEcCtD
Nitrofurantoin—Paraesthesia—Epirubicin—ovarian cancer	0.000138	0.00076	CcSEcCtD
Nitrofurantoin—Dyspnoea—Epirubicin—ovarian cancer	0.000137	0.000754	CcSEcCtD
Nitrofurantoin—Somnolence—Epirubicin—ovarian cancer	0.000136	0.000752	CcSEcCtD
Nitrofurantoin—Anorexia—Doxorubicin—ovarian cancer	0.000135	0.000746	CcSEcCtD
Nitrofurantoin—Nausea—Docetaxel—ovarian cancer	0.000135	0.000745	CcSEcCtD
Nitrofurantoin—Dyspepsia—Epirubicin—ovarian cancer	0.000135	0.000745	CcSEcCtD
Nitrofurantoin—Decreased appetite—Epirubicin—ovarian cancer	0.000133	0.000735	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000132	0.00073	CcSEcCtD
Nitrofurantoin—Constipation—Epirubicin—ovarian cancer	0.000131	0.000723	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000129	0.000713	CcSEcCtD
Nitrofurantoin—Paraesthesia—Doxorubicin—ovarian cancer	0.000127	0.000703	CcSEcCtD
Nitrofurantoin—Dyspnoea—Doxorubicin—ovarian cancer	0.000126	0.000698	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Epirubicin—ovarian cancer	0.000126	0.000697	CcSEcCtD
Nitrofurantoin—Somnolence—Doxorubicin—ovarian cancer	0.000126	0.000696	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000125	0.000692	CcSEcCtD
Nitrofurantoin—Dyspepsia—Doxorubicin—ovarian cancer	0.000125	0.000689	CcSEcCtD
Nitrofurantoin—Decreased appetite—Doxorubicin—ovarian cancer	0.000123	0.00068	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000122	0.000676	CcSEcCtD
Nitrofurantoin—Constipation—Doxorubicin—ovarian cancer	0.000121	0.000669	CcSEcCtD
Nitrofurantoin—Abdominal pain—Epirubicin—ovarian cancer	0.000121	0.000669	CcSEcCtD
Nitrofurantoin—Body temperature increased—Epirubicin—ovarian cancer	0.000121	0.000669	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000117	0.000645	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000116	0.00064	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Epirubicin—ovarian cancer	0.000113	0.000623	CcSEcCtD
Nitrofurantoin—Body temperature increased—Doxorubicin—ovarian cancer	0.000112	0.000619	CcSEcCtD
Nitrofurantoin—Abdominal pain—Doxorubicin—ovarian cancer	0.000112	0.000619	CcSEcCtD
Nitrofurantoin—Asthenia—Epirubicin—ovarian cancer	0.00011	0.000607	CcSEcCtD
Nitrofurantoin—Diarrhoea—Epirubicin—ovarian cancer	0.000105	0.000579	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000105	0.000577	CcSEcCtD
Nitrofurantoin—Asthenia—Doxorubicin—ovarian cancer	0.000102	0.000562	CcSEcCtD
Nitrofurantoin—Dizziness—Epirubicin—ovarian cancer	0.000101	0.000559	CcSEcCtD
Nitrofurantoin—Vomiting—Epirubicin—ovarian cancer	9.75e-05	0.000538	CcSEcCtD
Nitrofurantoin—Diarrhoea—Doxorubicin—ovarian cancer	9.71e-05	0.000536	CcSEcCtD
Nitrofurantoin—Rash—Epirubicin—ovarian cancer	9.67e-05	0.000533	CcSEcCtD
Nitrofurantoin—Headache—Epirubicin—ovarian cancer	9.61e-05	0.00053	CcSEcCtD
Nitrofurantoin—Dizziness—Doxorubicin—ovarian cancer	9.38e-05	0.000518	CcSEcCtD
Nitrofurantoin—Nausea—Epirubicin—ovarian cancer	9.11e-05	0.000502	CcSEcCtD
Nitrofurantoin—Vomiting—Doxorubicin—ovarian cancer	9.02e-05	0.000498	CcSEcCtD
Nitrofurantoin—Rash—Doxorubicin—ovarian cancer	8.95e-05	0.000494	CcSEcCtD
Nitrofurantoin—Headache—Doxorubicin—ovarian cancer	8.89e-05	0.00049	CcSEcCtD
Nitrofurantoin—Nausea—Doxorubicin—ovarian cancer	8.43e-05	0.000465	CcSEcCtD
